Trials / Completed
CompletedNCT04369118
Efficacy Study of a Selective Chest Wall Restriction Belt in Postoperative of Lung Resection
Efficacy Study of a Selective Chest Wall Restriction Belt in Postoperative of Lung Resection. A Multicenter, Prospective, Controlled, Randomized Study With Stratification on the Surgical Approach, Open With a Blind Analysis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy of a new medical device in post-surgery of lung resection. The principle of this new device is based on selective chest wall restriction. This new modality of chest wall restriction is evaluated on patients in post-surgery for lung cancer. The hypothesis is that the use of this medical device would reduce the postoperative pain and increase the efficacy of cough and expectoration. The evolution of the operated patient would be better.
Detailed description
The present study is the first evaluation of the efficacy of a selective chest wall restriction belt. The efficacy will be estimate on forced expiratory volume in one second (FEV1) at D3 by comparing 2 groups: a control group of patients with conventional follow-up and an experimental group of patients with conventional follow-up and a daily wear of the selective chest wall restriction belt after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Conventional follow-up | Patients in this group benefit from conventional post-operative follow-up |
| DEVICE | Conventional follow-up+chest wall restriction belt | Patients in this group benefit from conventional post-operative follow-up. The patient wear the selective chest wall restriction belt from Day 2 (after surgery) until he ceases to need it. |
Timeline
- Start date
- 2020-11-18
- Primary completion
- 2024-02-29
- Completion
- 2024-02-29
- First posted
- 2020-04-30
- Last updated
- 2024-05-17
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04369118. Inclusion in this directory is not an endorsement.